Blog
Simpson Manufacturing Q2 Earnings Call Highlights
Key Points
- Interested in Simpson Manufacturing Company, Inc.? Here are five stocks we like better.
- Strong Q2 performance: Simpson Manufacturing’s net sales rose 6.3% to $671.1 million, while
Cadence Design Systems Q2 Earnings Call Highlights
Key Points
- Interested in Cadence Design Systems, Inc.? Here are five stocks we like better.
- Strong Q2 performance: Revenue rose 24% year over year to $1.584 billion, beating guidance, while
Navitas Semiconductor Q2 Earnings Call Highlights
Key Points
- Interested in Navitas Semiconductor Corporation? Here are five stocks we like better.
- Revenue growth accelerated: Navitas reported Q2 revenue of $10.5 million, up 22% sequentially
Rambus Q2 Earnings Call Highlights
Key Points
- Interested in Rambus, Inc.? Here are five stocks we like better.
- Record second-quarter results: Rambus reported revenue of $207.4 million, up 20% year over year, and non-GAAP
Applied Digital Q4 Earnings Call Highlights
Key Points
- Interested in Applied Digital Corporation? Here are five stocks we like better.
- Revenue surged 407% year over year to $258.7 million, while adjusted EBITDA rose to $42.4 million
F5 Q3 Earnings Call Highlights
Key Points
- Interested in F5, Inc.? Here are five stocks we like better.
- F5 reported strong third-quarter results: Revenue rose 11% year over year to $865 million, exceeding guidance, while
OPKO Health Q2 Earnings Call Highlights
Key Points
- Interested in OPKO Health, Inc.? Here are five stocks we like better.
- OPKO Health narrowed its Q2 net loss to $8.4 million, or $0.01 per share, from $148.4 million a year earlier
Champions Oncology Q4 Earnings Call Highlights
Key Points
- Interested in Champions Oncology, Inc.? Here are five stocks we like better.
- Record fiscal 2026 performance: Revenue reached $59.4 million, up from the prior year, and adjusted
Amkor Technology Q2 Earnings Call Highlights
Key Points
- Interested in Amkor Technology, Inc.? Here are five stocks we like better.
- Record Q2 performance: Amkor reported revenue of $1.9 billion, up 26% year over year, while EPS reached
Agilysys Q1 Earnings Call Highlights
Key Points
- Interested in Agilysys, Inc.? Here are five stocks we like better.
- Record results lifted Agilysys’ outlook: Fiscal Q1 revenue rose 14.3% year over year to $87.7 million, while net
Bank of Hawaii Q2 Earnings Call Highlights
Key Points
- Interested in Bank of Hawaii Corporation? Here are five stocks we like better.
- Strong second-quarter performance: Bank of Hawaii reported net income of $63.8 million, or $1.47 per
AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
Key Points
- Interested in AirJoule Technologies Corporation? Here are five stocks we like better.
- AirJoule's deal with Kubota validates its technology and provides an exclusive sales channel for
Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
Key Points
- Interested in Altria Group, Inc.? Here are five stocks we like better.
- Dividend stocks can help investors manage market volatility when headline-driven swings make the market feel more
Trip.com Accepts China Antitrust Penalty, Overhauls Distribution and Pricing
Key Points
- Interested in Trip.com Group Limited Sponsored ADR? Here are five stocks we like better.
- Trip.com will comply with China’s antitrust penalty and end its Tier 1 and Tier 2 delegated
Hope Bancorp Q2 Earnings Call Highlights
Key Points
- Interested in Hope Bancorp, Inc.? Here are five stocks we like better.
- Second-quarter performance improved: Revenue rose 12% sequentially to $148 million, while adjusted EPS
Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
Key Points
- Interested in Valero Energy Corporation? Here are five stocks we like better.
- Renewed intensification of the Iran war has pushed crack spreads to record highs, boosting U.S. refiners
Maplight Therapeutics’ Schizophrenia Drug Hits Phase II Primary Endpoint
Key Points
- Interested in Maplight Therapeutics, Inc.? Here are five stocks we like better.
- ML-007C-MA met the Phase II primary endpoint in the ZEPHYR schizophrenia trial, with the twice-daily
Coca Cola Femsa Q2 Earnings Call Highlights
Key Points
- Interested in Coca Cola Femsa S.A.B. de C.V.? Here are five stocks we like better.
- Coca-Cola FEMSA delivered solid Q2 growth: Volume rose 3.5% to 1.1 billion unit cases, revenue
Bank of Marin Bancorp Q2 Earnings Call Highlights
Key Points
- Interested in Bank of Marin Bancorp? Here are five stocks we like better.
- Second-quarter profitability improved: Net income rose to $9.2 million, or $0.58 per share, while
Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Key Points
- Interested in Verizon Communications Inc.? Here are five stocks we like better.
- Verizon’s dark fiber deal with Alphabet gives the telecom company a direct connection to the AI
A $1.5 Billion Wake-Up Call for Every AI Company on Wall Street
Key Points
- Interested in Datavault AI Inc.? Here are five stocks we like better.
- A federal judge granted final approval to Anthropic's $1.5 billion settlement with authors, putting a real market
Kura Oncology Reports 50% Response Rate in RCC Combination Study
Key Points
- Interested in Kura Oncology, Inc.? Here are five stocks we like better.
- Kura Oncology reported encouraging efficacy signals for darlifarnib combined with cabozantinib in heavily
AMD’s AI Bubble Could Burst Into Explosive Upside
Key Points
- Interested in Advanced Micro Devices, Inc.? Here are five stocks we like better.
- AMD's expanded total addressable market forecasts and deep-value long-term earnings multiple suggest
Atlassian’s AI Pivot Is Starting to Challenge Wall Street’s Bear Case
Key Points
- Interested in Atlassian Corporation PLC? Here are five stocks we like better.
- Atlassian has been pressured by concerns that AI coding tools could reduce demand for Jira, Confluence and
Central Garden & Pet’s TRIXIE Deal Targets European Pet-Supplies Leadership
Key Points
- Interested in Central Garden & Pet Company? Here are five stocks we like better.
- Central Garden & Pet agreed to acquire a majority stake in Germany’s TRIXIE, valuing the deal at a